Corinne Chaimbault has a strong background in pharmaceutical development, with experience in managing CMC programs, leading drug product development, and overseeing intellectual property matters. Corinne has worked at various companies in roles such as Head of Pharmaceutical Development, CMC Manager, and Consultant CMC, providing expertise in bringing small molecule leads from discovery to clinics. With a PhD in Medicinal and Pharmaceutical Chemistry, Corinne has demonstrated skills in managing CROs, CMOs, and collaborating with pharmaceutical companies.
September, 2022 - present
January, 2020
Head of Pharmaceutical Development at Acticor Biotech
Head of Pharmaceutical Development at Nuclidium
Head of Pharmaceutical Development at Nuclidium
Head of Pharmaceutical Development and Manufacturing at Keros Therapeutics
Vice President Head Of Pharmaceutical Development at Sage Therapeutics